Liver transplantation for hepatocellular carcinoma: Current status in Hong Kong, China  

作　　者：Karin Ho Albert Chan 

机构地区：[1]Liver Transplant Center,Queen Mary Hospital,Department of Surgery,The University of Hong Kong,Hong Kong,China

出　　处：《Hepatobiliary & Pancreatic Diseases International》2025年第1期45-49,共5页国际肝胆胰疾病杂志(英文版)

摘　　要：With the advances in transplant oncology in recent years, the role of liver transplantation has expanded to make curative treatment a possibility for a wider patient population. We highlight strategies in Hong Kong, China that have enabled preoperative prognostication for judicious patient selection, downstaging therapy to definitive treatment, and postoperative therapies that have provided a growing role for liver transplantation in patients with more advanced hepatocellular carcinoma.

关 键 词：Living donor liver transplantation DOWNSTAGING Conversion therapy Transplant oncology 

分 类 号：R73[医药卫生—肿瘤]